Cansino Biologics Inc.Eigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 23.18 HKD | 56,55 HKD | 19,22 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 132.670.900 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Cansino Biologics Inc.
Mitarbeiter 1.134
Handelsplatz HK
Ticker Symbol 6185
IPO Datum -
Adresse 401-420, Biomedical Park, Tianjin, China, 300457
Webseite https://cansinotech.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Xuefeng Yu Ph.D. | Co-Founder, Executive Chairman, CEO & GM |
| 2 | Dr. Shou-Bai Chao Ph.D. | COO, Deputy GM & Executive Director |
| 3 | Ms. Jing Wang | Chief Commercial Officer, Deputy GM & Executive Director |
| 4 | Dr. Tao Zhu Ph.D. | Co-Founder, Deputy GM & Chief Scientific Officer |
| 5 | Dr. Dongxu Qiu MBA, Ph.D. | Co-Founder, Executive VP & Deputy GM |
| 6 | Ming Liu | Acting Head of Finance |
| 7 | Bei Bei Gao | Accounting Supervisor |
| 8 | Mr. Chunlin Xin | Senior Director of New Technology Department |
| 9 | Mr. Yonghui Wu | Vice President of Marketing |
| 10 | Mr. Jin Cui | Board Secretary |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.